LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
NASDAQ:LIVN
Price:
61.95 USD
-0.74%
Market Closed
Updated:
May 10, 2024
LivaNova PLC
Total Equity
|
LivaNova PLC
Total Equity Peer Comparison
Comparables:
SN
LMDX
EKF
AGL
CREO
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Total Equity
$1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
17%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Total Equity
$5.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Total Equity
-$105.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Total Equity
£67.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
Angle PLC
LSE:AGL
|
Total Equity
£32.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Total Equity
£49.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Total Equity?
Total Equity
1.2B
USD
1.2B
USD
Based on the financial report for Mar 31, 2024, LivaNova PLC's Total Equity amounts to 1.2B USD.
What is LivaNova PLC's Total Equity growth rate?
Total Equity CAGR 10Y
17%
17%
Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for LivaNova PLC have been 5% over the past three years , -4% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
